hte to Deliver Technology and Service to Flanders Materials Centre
News Oct 07, 2005
hte Aktiengesellschaft, the high throughput experimentation company, has entered into a 3-year collaboration agreement with the Flanders Materials Centrein Belgium (Flamac). hte will deliver a series of integrated solutions for high throughput formations researchThe workflows to be created by hte will encompass sample preparation, application and characterization and will integrate proprietary innovations along with component instruments from a number of third party vendors to speed up materials research.
Critical to the successful roll-out of these workflows, hte's comprehensive suite of software technologies will provide the essential experimental design, process control, data management and data analysis capabilities for this complete research infrastructure.
Consulting, maintenance and support services provided by hte will ensure that the collaboration between both parties benefits from hte's extensive experience in integrating and operating high-throughput R & D facilities. hte and Flamac expect delivery of the first integrated research workflow to Flamac's new research centre in Ghent, Belgium, in early 2006.
"With this collaboration we see hte's expertise and validated technologies for high throughput experimentation being brought to yet another field of R & D," commented Dirk Demuth, CEO of hte, "We are delighted to have this opportunity to implement high-productivity solutions for formulations research in partnership with the Flanders Materials Centre."
"The agreement with hte is one more important step towards establishing Flamac as a provider of high-throughput services to materials companies and the materials science community", stated Luc Gellens, chairman of Flamac. "We look forward to a successful collaboration with hte."
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
‘Good Cholesterol’ May Not Always be Good for Postmenopausal WomenNews
Postmenopausal factors may have an impact on the heart-protective qualities of high-density lipoproteins (HDL) – also known as ‘good cholesterol’ – according to a study led by researchers in the University of Pittsburgh Graduate School of Public Health.READ MORE
What Makes Good Brain Proteins Turn Bad?News
The protein FUS is implicated in two neurodegenerative diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Using a newly developed fruit fly model, researchers have zoomed in on the protein structure of FUS to gain more insight into how it causes neuronal toxicity and disease.